| Tag | Content |
|---|
EnhancerAtlas ID | HS176-12645 |
Organism | Homo sapiens |
Tissue/cell | SK-N-SH |
Coordinate | chr14:64700950-64701680 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| ZNF263 | MA0528.1 | chr14:64701019-64701040 | CCCCTCCCCTCCTCCAGCTCC | - | 6.37 | | ZNF263 | MA0528.1 | chr14:64701008-64701029 | CCTTCCACCCTCCCCTCCCCT | - | 6.63 | | ZNF263 | MA0528.1 | chr14:64701013-64701034 | CACCCTCCCCTCCCCTCCTCC | - | 6.98 |
|
| | Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
| SE_10782 | chr14:64700800-64703816 | CD19_Primary | | SE_58342 | chr14:64635418-64706815 | Ly1 | | SE_59566 | chr14:64660997-64704625 | Ly3 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH14I064234 | chr14 | 64700805 | 64703691 |
|
Enhancer Sequence | GTGTATATTG TCCTTCTCCA CAGCCTCTAG ACTTGCCTCC TCAGTGACCA GTTAATTACC 60
TTCCACCCTC CCCTCCCCTC CTCCAGCTCC AGGGCAAGGC TACCCTCATC GTGGGTGACA 120
CCAAGCACTG AGCATCATTG TACCAACAGT AGCCACCACT GCACACCCTC TTCATCAGCA 180
CACACAATTA CGTTTCCTGA TCAGAAACAT GCCCTACCTA CAGCCCTGCC TTCCTAAATC 240
TGCTGGGTCC ACCACTTCTC TTAAGTCTTA TCCTTAATTT CCTGATGCCA CCGAAAGAAC 300
AACTCTTAGG GAAGCATTTG TGCACTTCTT CGCATCACCA GCTCGAGGGG CCATCTAGGG 360
GAGCGGGTCT TAGCCTCTCC ACAAAAAGTG GCCTCAGGGC CTCAGCCCTG GGTGGTGTAA 420
ACAGGGGTGG CAGTTCGTGT TAGGGGAGGA ACTGCCCCTT TTAGGACTCC ATAAACAGGC 480
TATAAACCCC AGCAATTGAA AAACCCATGA GCCACCACTG GCTGCCATGC AGAGCCTGTA 540
AGATACCACA TGACATTCCT TCCATGCCCA CTCTGTGCCC ATCTTTGCTT ACAGGTGTGT 600
GAACTGACAA ATTCCCCATT CCCTTTCAGG CATTCATTTT CCTTAACTTG CAGACACTTT 660
TCCCAAATCA CTTCACCCTC CGTGGAGCAC ATAATCCCAT CCCAAGCCCA AGCAGAGCAG 720
CTCCTTAGGG 730
|
